SRS16-86
SRS16-86 is a potent inhibitor of ferroptosis[1]. SRS16-86 is more stable than more stable to metabolism and plasma than Ferrostatin-1 in vivo. SRS16-86 can be used for renal ischemia-reperfusion injury (IRI) and spinal cord injury (SCI) research[2][3].
Product Specifications
CAS Number
1793052-96-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ferroptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/srs16-86.html
Purity
98.0
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C) |DMSO : 8.33 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(C1=CC(/N=C\C2=CN=CN=C2)=C(C=C1)NC3(C[C@H](C4)C5)C[C@H]5C[C@H]4C3)OC(C)(C)C
Molecular Formula
C26H32N4O2
Molecular Weight
432.56
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
4-Ethylpiperazine-1-sulfonyl chloride hydrochloride
4-Ethylpiperazine-1-sulfonyl chloride hydrochloride
50 L Sinlge-Use Open bag -B
ZytoLight® SPEC ERBB2/D17S122 Dual Color Probe